Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest biopharmaceutical Stories

2013-06-30 23:00:29

Growth in the Biotechnology industry is likely to accelerate over the next five years through 2018-19 as the economy recovers and will be supported by government programmes to encourage private sector investment. The ageing population and increasing incidence of health decline are anticipated to stimulate demand for biopharmaceuticals, reduce opposition to new treatments and draw capital to the industry. London, United Kingdom (PRWEB) July 01, 2013 The Biotechnology industry is fast...

2013-06-21 12:24:05

National Institutes of Health, KY Cabinet for Economic Development and Angel Investors Combine for $4,330,426 to Lexington, KY-based Biotech Firm LEXINGTON, Ky., June 21, 2013 /PRNewswire-iReach/ -- Transposagen Biopharmaceuticals, Inc., based in Lexington, KY, has announced today that it is the recipient of over $2,975,426 in additional Small Business Innovation Research (SBIR) funding; $1,975,426 from the National Institutes of Health (NIH) and $1,000,000 from the KY Cabinet for...

2013-06-18 08:29:52

THE WOODLANDS, Texas, June 18, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that John Northcott has joined the company as its vice president of marketing, commercial strategy, and operations. Mr. Northcott brings extensive commercial experience to Lexicon, including both pre-launch planning and on-market commercialization across a variety of therapeutic areas....

2013-06-18 08:29:16

- Golfer is the first to take online Pledge, an outlet for epilepsy patients and caregivers to take action and ask themselves, "Am I really okay?" ATLANTA, June 18, 2013 /PRNewswire/ -- regulated information -- Global biopharmaceutical company UCB, Inc. and professional golfer Jeff Klauk today announced the launch of a new Pledge campaign for people with epilepsy and their loved ones. The Pledge empowers the millions of Americans living with epilepsy to take a stand and make a...

2013-06-17 16:25:19

SAN FRANCISCO, June 17, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Donald R. Joseph as Chief Legal Officer. Mr. Joseph brings to KaloBios almost 20 years of biopharmaceutical industry experience and has worked in both public and private companies, as well as major global health non-profit organizations. (Logo: http://photos.prnewswire.com/prnh/20130225/MM66380LOGO) "Don has a long and successful track record as a general counsel...

2013-06-17 04:23:01

SOUTH SAN FRANCISCO, Calif., June 17, 2013 /PRNewswire/ -- NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell (EEC) program for the treatment of type 2 diabetes and obesity. EECs represent less than 1% of all gastrointestinal (GI) cells, but produce virtually all of the known...

2013-06-13 12:29:37

ROCKVILLE, Md., June 13, 2013 /PRNewswire/ -- RRD International, a product development company that provides expert-level strategic, regulatory and operational support to biopharmaceutical companies and investors, announced today the appointment of J. Scott Tarrant as its President. Mr. Tarrant joined RRD in 2010 as Chief Business Officer and has been responsible for shepherding the company's strategic growth initiatives. "Scott has played a pivotal role in the company's growth and...

2013-06-12 16:27:09

BELLEVILLE, ON, June 12, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today issued an open letter to all shareholders from Founder, President & CEO, Graeme McRae: Dear Fellow Shareholders, By now you have seen the many press releases accompanying the requisition by Bill Wells and Greg Gubitz for a shareholders' meeting to make changes to the Board of Directors (Board) of...

2013-06-04 08:28:52

ST LOUIS, June 4, 2013 /PRNewswire/ -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC(®) Commercial (www.safcglobal.com), its custom manufacturing services business unit, has won commercial sales and licensing contracts with two leading Asian biopharmaceutical companies for the purchase of CHOZN(®), their off-the-shelf cell line production platform. The contracts feature the CHOZN(®) Platform system as a key component of each customer's global biotherapeutic...

2013-06-03 04:21:08

-Conference Call Today at 8:00 a.m. ET, 1:00 p.m. BST- LONDON, June 3, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results for the second quarter and half year ended 31 March 2013. CORPORATE HIGHLIGHTS Initial public offering on the NASDAQ Global...